Cost-Utility Analysis of Secukinumab Use Versus TNF-Α Inhibitors, in Patients With Ankylosing Spondilytis
Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.2980
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Publisher
Elsevier BV